Your browser doesn't support javascript.
loading
Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
Stoeck, Alexander; Lejnine, Serguei; Truong, Andrew; Pan, Li; Wang, Hongfang; Zang, Chongzhi; Yuan, Jing; Ware, Chris; MacLean, John; Garrett-Engele, Philip W; Kluk, Michael; Laskey, Jason; Haines, Brian B; Moskaluk, Christopher; Zawel, Leigh; Fawell, Stephen; Gilliland, Gary; Zhang, Theresa; Kremer, Brandon E; Knoechel, Birgit; Bernstein, Bradley E; Pear, Warren S; Liu, X Shirley; Aster, Jon C; Sathyanarayanan, Sriram.
Afiliación
  • Stoeck A; Merck Research Laboratory, Boston, Massachusetts. ssathy@jouncetx.com jaster@rics.bwh.harvard.edu Alexander.Stoeck@merck.com.
  • Lejnine S; Merck Research Laboratory, Boston, Massachusetts.
  • Truong A; Merck Research Laboratory, Boston, Massachusetts.
  • Pan L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Wang H; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Zang C; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Yuan J; Merck Research Laboratory, Boston, Massachusetts.
  • Ware C; Merck Research Laboratory, Boston, Massachusetts.
  • MacLean J; Merck Research Laboratory, Boston, Massachusetts.
  • Garrett-Engele PW; Merck Research Laboratory, Boston, Massachusetts.
  • Kluk M; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Laskey J; Merck Research Laboratory, Boston, Massachusetts.
  • Haines BB; Merck Research Laboratory, Boston, Massachusetts.
  • Moskaluk C; Department of Medicine and Digestive Health Research Center, University of Virginia, Charlottesville, Virginia.
  • Zawel L; Merck Research Laboratory, Boston, Massachusetts.
  • Fawell S; Merck Research Laboratory, Boston, Massachusetts.
  • Gilliland G; Merck Research Laboratory, Boston, Massachusetts.
  • Zhang T; Merck Research Laboratory, Boston, Massachusetts.
  • Kremer BE; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Knoechel B; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Pear WS; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Liu XS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Aster JC; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Sathyanarayanan S; Merck Research Laboratory, Boston, Massachusetts. ssathy@jouncetx.com jaster@rics.bwh.harvard.edu Alexander.Stoeck@merck.com.
Cancer Discov ; 4(10): 1154-67, 2014 Oct.
Article en En | MEDLINE | ID: mdl-25104330

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Carcinoma Adenoide Quístico / Secretasas de la Proteína Precursora del Amiloide / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Discov Año: 2014 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Carcinoma Adenoide Quístico / Secretasas de la Proteína Precursora del Amiloide / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Discov Año: 2014 Tipo del documento: Article